Notes / Company

Dr. Lal Pathlabs Ltd.

LALPATHLAB BSE 539524 ISIN INE600L01024 Diagnostics

Fundamentals

Market cap: ₹28,317 cr
P/E: 56.10×
ROE: 22.42%
Debt / equity: 0.00
Div yield: 1.24%
52-week range: 1272.60 — 1803.00

Research on Tijori Finance

Company snapshot

Dr. Lal Pathlabs Ltd.

Diagnostic Chains

₹28,408 cr

P/E 56.28×

Latest quarter · Mar 2026

Sales₹703 cr

Net profit₹132 cr

Op. margin+26.6%

EPS₹7.83

Strength & growth

Debt / equity0.00×

Current ratio3.48×

Sales CAGR+13.3%

EPS CAGR+13.1%

The timeline — 1 note on Dr. Lal Pathlabs Ltd.

July 2026

17 Jul 26 · 7:43 PM IST Brief

Brief · Order Wins · Large cap

Dr. Lal PathLabs wins ₹32.66 cr ESOP tax dispute

Tax appellate order overturns a 2024 assessment disallowing the deduction, removing a contingent liability. The amount is small relative to revenue of over ₹2,700 cr.

Verify on exchange BSE filings for LALPATHLAB NSE filings for LALPATHLAB Tijori Finance company page